About Sight Sciences
Sight Sciences is a company based in Menlo Park (United States) founded in 2006.. Sight Sciences has raised $128.59 million across 10 funding rounds from investors including Janus Henderson Investors, MidCap Financial and KCK MedTech. The company has 216 employees as of December 31, 2024. Sight Sciences operates in a competitive market with competitors including Alcon, Iantrek, Keranova, Orbit Biomedical and Migos Medical, among others.
- Headquarter Menlo Park, United States
- Employees 216 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Sight Sciences, Inc.
-
Annual Revenue
$79.87 M-1.47as on Dec 31, 2024
-
Net Profit
$-51.51 M7.27as on Dec 31, 2024
-
EBITDA
$-49.82 M12.07as on Dec 31, 2024
-
Total Equity Funding
$128.59 M (USD)
in 10 rounds
-
Latest Funding Round
$23.25 M (USD), Series E
Dec 03, 2020
-
Investors
Janus Henderson Investors
& 5 more
-
Employee Count
216
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sight Sciences
Sight Sciences is a publicly listed company on the NASDAQ with ticker symbol SGHT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Sales and Marketing
52 people
Leadership Team
25 people
Software Development Team
11 people
Product Management Team
8 people
Senior Team
7 people
Finance and Accounting
6 people
Glaucoma Team
4 people
Legal and Compliance
3 people
Unlock access to complete
Funding Insights of Sight Sciences
Sight Sciences has successfully raised a total of $128.59M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $23.25 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series E — $23.2M
-
First Round
First Round
(27 Sep 2011)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Series E - Sight Sciences | Valuation | Janus Henderson Investors |
|
| Dec, 2020 | Amount | Debt – Conventional - Sight Sciences | Valuation |
investors |
|
| Mar, 2020 | Amount | Series E - Sight Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sight Sciences
Sight Sciences has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Janus Henderson Investors, MidCap Financial and KCK MedTech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Private debt funds are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sight Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sight Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sight Sciences Comparisons
Competitors of Sight Sciences
Sight Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alcon, Iantrek, Keranova, Orbit Biomedical and Migos Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a wide range of eye care products
|
|
| domain | founded_year | HQ Location |
Developer of a minimally invasive eye surgery technology
|
|
| domain | founded_year | HQ Location |
Surgical equipment for anterior chamber ophthalmic surgery is developed.
|
|
| domain | founded_year | HQ Location |
Medical device for ophthalmic surgery is developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive ophthalmology devices for glaucoma are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sight Sciences
Frequently Asked Questions about Sight Sciences
When was Sight Sciences founded?
Sight Sciences was founded in 2006 and raised its 1st funding round 5 years after it was founded.
Where is Sight Sciences located?
Sight Sciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Sight Sciences a funded company?
Sight Sciences is a funded company, having raised a total of $128.59M across 10 funding rounds to date. The company's 1st funding round was a Series E of $30.15M, raised on Sep 27, 2011.
How many employees does Sight Sciences have?
As of Dec 31, 2024, the latest employee count at Sight Sciences is 216.
What is the annual revenue of Sight Sciences?
Annual revenue of Sight Sciences is $79.87M as on Dec 31, 2024.
What does Sight Sciences do?
Sight Sciences was established in 2006 in Menlo Park, United States, within the medical device sector focused on ophthalmology. Surgical instruments and systems are created for managing conditions like primary open-angle glaucoma, Meibomian Gland Dysfunction, dry eye, and blepharitis. These tools support canaloplasty procedures aimed at lowering intraocular pressure among adult patients, with operations centered on innovation in eye care technologies.
Who are the top competitors of Sight Sciences?
Is Sight Sciences publicly traded?
Yes, Sight Sciences is publicly traded on NASDAQ under the ticker symbol SGHT.
Who are Sight Sciences's investors?
Sight Sciences has 6 investors. Key investors include Janus Henderson Investors, MidCap Financial, KCK MedTech, Allegro Investment Fund, and SHD Partners.
What is Sight Sciences's ticker symbol?
The ticker symbol of Sight Sciences is SGHT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.